Clinical Research Directory
Browse clinical research sites, groups, and studies.
Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular Carcinoma
Sponsor: Chinese University of Hong Kong
Summary
This is a single-centre, prospective cohort study. Consecutive patients with compensated liver disease and hepatocellular carcinoma (HCC) for curative-intent treatment will be invited to this study. The study follow-up duration will be five years. The primary outcome is the composite of incident high-risk varices, hepatic decompensation and liver-related mortality. The participants will undergo transient elastography at baseline and then half-yearly post-HCC curative treatment; and oesophagogastroduodenoscopy (OGD) at baseline and then at year 1, 3 and 5 post-HCC curative treatment. Clinical assessments and laboratory tests will also be done at baseline and every 6 months until year 5 to identify any clinical events.
Official title: Validation of Baveno VII Criteria and Spleen Stiffness Measurement on Outcome Prediction in Patients With Hepatocellular Carcinoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
159
Start Date
2024-11-04
Completion Date
2030-12
Last Updated
2025-06-29
Healthy Volunteers
No
Conditions
Interventions
transient elastography and oesophagogastroduodenoscopy
Liver and spleen stiffness will be measured by transient elastography. Varices will be identified by oesophagogastroduodenoscopy.
Locations (1)
Prince of Wales Hospital
Hong Kong, Hong Kong